Whole Exome Sequencing
Whole Exome Sequencing (WES) provides comprehensive insights into the genetic landscape, focusing on protein-coding regions where most disease-associated variants are found. It enables the detection of single-nucleotide polymorphisms (SNPs), insertions, and deletions (InDels), offering a more cost-effective alternative to whole genome sequencing (WGS).
At Eurofins, we offer Agilent’s Human WES and Clinical Research Exome solutions for research use only (RUO), as well as GCP-compliant services in our accredited laboratory. We are also proud to have been the first to introduce WES for circulating cell-free DNA (cfDNA) enabling non-invasive cancer profiling.